406 related articles for article (PubMed ID: 33030278)
1. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.
Gong Z; Zhang J; Guo W
Cancer Med; 2020 Dec; 9(23):9052-9063. PubMed ID: 33030278
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer.
Wu M; Wang Y; Liu H; Song J; Ding J
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338286
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel immune prognostic model in gastric cancer.
Li Y; He X; Fan L; Zhang X; Xu Y; Xu X
Clin Transl Oncol; 2021 Apr; 23(4):846-855. PubMed ID: 32857339
[TBL] [Abstract][Full Text] [Related]
8. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment.
Wang D; Jiao Z; Ji Y; Zhang S
J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338
[TBL] [Abstract][Full Text] [Related]
9. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
[No Abstract] [Full Text] [Related]
10. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
11. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
12. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
13. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
14. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
[TBL] [Abstract][Full Text] [Related]
15.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
16. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
17. Immune infiltration profiling in gastric cancer and their clinical implications.
Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
[TBL] [Abstract][Full Text] [Related]
18. Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
Feng W; Wang Y; Chen S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):24333-24344. PubMed ID: 33259333
[TBL] [Abstract][Full Text] [Related]
19. Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer.
Wang Y; Chen L; Yu M; Fang Y; Qian K; Wang G; Ju L; Xiao Y; Wang X
Cancer Med; 2020 Oct; 9(20):7729-7741. PubMed ID: 32841548
[TBL] [Abstract][Full Text] [Related]
20. LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer.
Ran T; Chen Z; Zhao L; Ran W; Fan J; Hong S; Yang Z
Technol Cancer Res Treat; 2021; 20():15330338211004944. PubMed ID: 33784890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]